ViiV Healthcare announces results from STRIIVING HIV-1 study
ViiV Healthcare announced on Wednesday 24-week data from the Phase IIIb/IV Striiving study, an open-label study evaluating the efficacy, safety…
Pharmaceuticals, Biotechnology and Life Sciences
ViiV Healthcare announced on Wednesday 24-week data from the Phase IIIb/IV Striiving study, an open-label study evaluating the efficacy, safety…
FDA is warning health care professionals about the risk for dosing errors with the intravenous antibacterial drug Avycaz (ceftazidime and…
US presidential candidate from Democratic party, Hilary Clinton, has announced to make a plan about pricing medicine. After the news spread…
Bayer announced on September 22 that Bayer CropScience and the civil organization Round Table on Responsible (RTRS) are uniting to…
Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system (CNS)…
Quantum Pharma a service-led niche pharmaceutical manufacturer, developer and supplier to the health and care sectors has anounced first large-scale NHS homecare contract…
Simulations Plus, Inc, a provider of consulting services and software for pharmaceutical discovery and development, announced on September 17 that…
DEA Acting Administrator Chuck Rosenberg has announced that the 10th National Prescription Drug Take-Back will take place September 26 from…
The Supervisory Board of Bayer has approved the reorganization proposed by the Board of Management, so that from January 1,…
You must be logged in to post a comment.